Another target gene of the IFN-γ pathway is IFI30, which encodes for the IFN-γ-inducible lysosomal thiol reductase (GILT) and is considered one of the causal risk variants in MS (7). The gene discussed is IFI30; the disease is myeloid sarcoma.